You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.
Enhanced gene coverage, plus the option of multiplex viral detection. When you need to know if it’s the flu, COVID-19, or RSV, choose a testing duo that delivers more. With our growing respiratory portfolio, Cepheid offers fast and accurate options to deliver more than results. Whatever your testing needs, Cepheid has you covered.
Coverage, plus
Accuracy, plus
Peace of mind
That’s the PCRplus advantage. From Cepheid
Meet the challenges of the ongoing pandemic with the confidence of a single test to detect and differentiate SARS-CoV-2, Flu A, Flu B, and RSV. Results for all four pathogens in just 36 minutes.
More testing options to support care. Designed with enhanced gene coverage to test symptomatic and asymptomatic patients. Rapid on-demand detection of SARS-CoV-2.
9/14/21: Cepheid Receives Emergency Use Authorization for Xpert Xpress CoV-2/Flu/RSV plus
3/21/2020: Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test
3/22/20: HHS, DoD collaborate with Cepheid on rapid diagnostics to detect coronavirus infections
2/10/2020: Cepheid Announces Development of Test for New Coronavirus Strain (2019-nCoV)
Below is a list of common questions and answers for Cepheid’s SARS-CoV-2 tests.
For additional information please
Cepheid has launched the Xpert® Xpress CoV-2/Flu/RSV plus and Xpert® Xpress CoV-2 plus tests with three gene targets (E, N2, and RdRP) for SARS-CoV-2 to enable detection of current and future variants of the SARS-CoV-2 virus. The tests are designed for broad coverage to mitigate the possible effects of viral genetic drift.
Cepheid’s tests are well suited for pandemic response. From the time a sample (such as a nasopharyngeal swab) is taken, a result can be obtained in less than an hour on our automated systems. We call this “sample to answer” and the samples can be loaded as they are received for true on-demand testing. It takes less than a minute to prepare the cartridge with the patient sample. Xpert® Xpress CoV-2/Flu/RSV plus can report positives for SARS-CoV-2 in as little as 25 minutes* and Xpert® Xpress CoV-2 plus tests can report a positive result as soon as 20 minutes^
Click the green Request Information button at the top of this page to be connected with your local Cepheid Sales Representative.
All of Cepheid’s SARS-CoV-2 tests, including Xpert® Xpress CoV-2/Flu/ or RSV plus and Xpert® Xpress CoV-2 plus, can be run on GeneXpert® II, IV, XVI, Infinity 48, Infinity 80.
The tests are designed to detect SARS-CoV-2, the virus that causes COVID-19. Xpert Xpress CoV-2/Flu/RSV plus and Xpert Xpress CoV-2 plus target the E, N2 and RdRP genes for robust detection of SARS-CoV-2.
Xpert® Xpress CoV-2/Flu/RSV plus and Xpert® Xpress CoV-2 plus support a variety of sample types including nasopharyngeal and anterior nasal swabs in UTM/VTM, saline, or eNAT. Additional information, including sample types for Cepheid’s other SARS-CoV-2 tests, can be found on the product resource page at www.cepheid.com/coronavirus-resources and in the package inserts.#
